Resmed (RMD) shares led the S&P 500 higher, skyrocketing 18.9% after the health care technology company posted better-than-expected quarterly revenue and earnings results. Demand for Resmed's products remained strong, particularly its sleep devices, and the company refuted concerns that the growing use of weight-loss drugs could subdue sales.
Buy RMD now and get great upside returns in a year or two, page-169
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$31.55 |
Change
0.950(3.10%) |
Mkt cap ! $19.99B | |||
| Open | High | Low | Value | Volume |
| $31.67 | $31.78 | $31.33 | $56.13M | 1.779M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $31.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $31.59 | 3593 | 3 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| RMD (ASX) Chart |